Blog Layout

Using electronic health record data: a machine learning approach with a 2-year horizon

In the United States, end-stage kidney disease (ESKD) is responsible for high mortality and significant healthcare costs, with the number of cases sharply increasing in the past 2 decades. In this study, we aimed to reduce these impacts by developing an ESKD model for predicting its occurrence in a 2-year period.



Lead Author: Panayiotis Petousis, PhD

End-stage kidney disease (ESKD) poses a substantial burden for mortality rate and healthcare costs in the United States. We developed and

evaluated a machine learning (ML) model for predicting ESKD in 2 years using electronic health record (EHR) data. Various models were tested

by leveraging EHR data and employing an ML pipeline. The developed model outperforms existing kidney failure models. Through a chart

review, expert nephrologists affirmed the clinical utility of the model in predicting the outcome of complex cases. This model has been successfully

integrated into our academic institution as part of a dashboard with visualizations and explainability for the model’s predictions. In conclusion,

the developed ESKD prediction model demonstrates the ability to identify individuals at risk for ESKD. Any future reduction in mortality

and healthcare costs would showcase the effectiveness of our model.


Key words: machine learning deployment; early prediction ESKD model; electronic health record; end-stage kidney disease (ESKD).


Link to Full Article

Share this Article with others

By Sorena Nadaf February 13, 2025
January 2025 Newsletter: The Year of Artificial Intelligence Sorena Nadaf-Rahrov, MS, MMI, PhDc
By Sorena Nadaf February 5, 2025
A recent Lancet study demonstrated that AI implementation led to a 29% increase in cancer detection, with no increase in false positives and a reduced workload compared to radiologists without AI assistance. While emerging evidence supports AI’s potential to enhance cancer detection in mammography screening and reduce screen-reading workload, further research is needed to fully understand its clinical impact.
By Sorena Nadaf December 10, 2024
Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry
By Sorena Nadaf November 11, 2024
With heavy hearts, we remember and honor Brady Davis, whose sudden passing leaves an immense void. Brady was a devoted supporter and invaluable contributor to the Cancer Center Informatics Society, dedicating countless hours to advancing our mission and strengthening our community. His expertise, enthusiasm, and unwavering commitment shaped our initiatives and inspired everyone fortunate enough to work alongside him. Brady’s legacy will live on through the progress he championed and the connections he fostered. We extend our deepest sympathies to his family, friends, and all who knew him. He will be greatly missed. In honor of Brady’s legacy, Ci4CC will be forming a committee to explore meaningful ways to memorialize him within our society for years to come. We plan to announce the committee’s recommendations at our Spring Summit in San Diego, CA, on March 31, 2025. Please find his obituary here , and visit his memorial page on MyKeeper to leave a tribute. Support the Davis family in Brady’s memory via GoFundMe ---------- Cancer Center Informatics Society (Ci4CC) Sorena Nadaf-Rahrov & Warren Kibbe Co-Founders, Ci4CC
By Sorena Nadaf October 29, 2024
Nature Digital Medicine PRISM: Patient Records Interpretation for Semantic clinical trial Matching system using large language models
By Sorena Nadaf September 4, 2024
American Cancer Society and Color Health to Provide Free At-Home Colorectal Cancer Screening in Underserved Rural Communities
September 4, 2024
Leading Progress Against Cancer
August 24, 2024
By Drs Karen Knudsen & Othman Laraki.
By Sorena Nadaf July 18, 2024
Conversation with The Cancer Letter: NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready” - July 12, 2024
By Sorena Nadaf July 11, 2024
"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019" American Cancer Society
Share by: